Oct 21 2026 | By: Burzynski Clinic
A cancer treatment plan may change when new information alters the balance of benefit, risk, and patient goals. Imaging, laboratory values, side effects, pathology, biomarkers, disease progression, new evidence, or a change in priorities can all affect the next decision. A change should come with a clear explanation of what triggered it and how the new plan will be monitored.
This article is educational and does not provide individualized medical advice. A qualified clinician should interpret records, tests, risks, and treatment options for the specific patient.
Imaging, tumor markers when appropriate, symptoms, physical findings, and function can help the team judge whether the disease is responding, stable, or progressing. One result may not tell the whole story, so clinicians may compare trends and consider timing, test limitations, and the patient's condition.
Laboratory abnormalities, organ function, medication interactions, and side effects can make a dose or drug unsafe or difficult to continue. A plan can be adjusted to reduce harm, manage toxicity, or preserve day-to-day function. Patients should know which symptoms require an urgent call.
A pathology review, repeat biopsy, or biomarker result may change how the cancer is classified or which treatments deserve discussion. New research or trial availability can also affect options. Not every new finding is actionable, and every option still requires a risk-benefit review.
Treatment decisions should reflect what matters to the patient. Goals may shift with health, family circumstances, symptoms, travel burden, or understanding of the likely outcomes. Ask the team to restate the current goal and explain how the proposed change supports it.
Burzynski Clinic reviews medical records before an initial consultation is scheduled. The clinic's prospective patient process lists the records recommended for evaluation and explains how patients may provide records or authorize the clinic to request them. Initial consultations take place in person at the Houston clinic.
Burzynski Clinic is located at 9432 Katy Freeway, Houston, Texas 77055. Stanislaw R. Burzynski, MD, PhD, Founder. Learn about individualized treatment planning or call 1-713-335-5697 for United States and international inquiries.